Pfizer Inc (PFE)
25.14
+0.20
(+0.78%)
USD |
NYSE |
Nov 21, 16:00
25.08
-0.06
(-0.22%)
After-Hours: 18:04
Pfizer Market Cap: 142.44B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 141.33B |
| November 19, 2024 | 142.24B |
| November 18, 2024 | 140.88B |
| November 15, 2024 | 140.54B |
| November 14, 2024 | 147.46B |
| November 13, 2024 | 151.42B |
| November 12, 2024 | 148.42B |
| November 11, 2024 | 148.70B |
| November 08, 2024 | 151.42B |
| November 07, 2024 | 155.62B |
| November 06, 2024 | 155.05B |
| November 05, 2024 | 158.62B |
| November 04, 2024 | 157.32B |
| November 01, 2024 | 159.19B |
| October 31, 2024 | 160.38B |
| October 30, 2024 | 161.62B |
| October 29, 2024 | 161.25B |
| October 28, 2024 | 163.52B |
| October 25, 2024 | 161.20B |
| October 24, 2024 | 162.27B |
| October 23, 2024 | 163.52B |
| October 22, 2024 | 163.41B |
| October 21, 2024 | 163.92B |
| October 18, 2024 | 165.56B |
| October 17, 2024 | 165.84B |
| Date | Value |
|---|---|
| October 16, 2024 | 168.11B |
| October 15, 2024 | 166.81B |
| October 14, 2024 | 164.77B |
| October 11, 2024 | 165.22B |
| October 10, 2024 | 166.24B |
| October 09, 2024 | 171.06B |
| October 08, 2024 | 165.33B |
| October 07, 2024 | 165.45B |
| October 04, 2024 | 161.93B |
| October 03, 2024 | 160.57B |
| October 02, 2024 | 162.10B |
| October 01, 2024 | 162.44B |
| September 30, 2024 | 163.97B |
| September 27, 2024 | 164.84B |
| September 26, 2024 | 164.16B |
| September 25, 2024 | 163.94B |
| September 24, 2024 | 167.17B |
| September 23, 2024 | 166.09B |
| September 20, 2024 | 166.71B |
| September 19, 2024 | 168.07B |
| September 18, 2024 | 168.58B |
| September 17, 2024 | 169.04B |
| September 16, 2024 | 170.40B |
| September 13, 2024 | 165.86B |
| September 12, 2024 | 165.24B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
140.54B
Minimum
Nov 15 2024
343.79B
Maximum
Dec 16 2021
216.19B
Average
204.67B
Median
Aug 21 2020
Market Cap Benchmarks
| Amgen Inc | 155.82B |
| Johnson & Johnson | 374.39B |
| Eli Lilly and Co | 711.90B |
| Merck & Co Inc | 252.58B |
| Moderna Inc | 14.72B |
Market Cap Related Metrics
| PE Ratio | 33.97 |
| PS Ratio | 2.407 |
| Price to Book Value | 1.543 |
| Price to Free Cash Flow | 17.37 |
| Price | 25.14 |
| Earnings Yield | 2.94% |
| Operating PE Ratio | 15.81 |
| Normalized PE Ratio | 16.19 |